Tag: MMED
MindMed Announces the Approval of Mescaline Study
Posted by Editorial Staff | May 20, 2021 | Press Release | 0
The Chopra Foundation and MindMed Enter Into Lette...
Posted by Editorial Staff | May 18, 2021 | Press Release | 0
MindMed Announces Launch of Collaboration with Nextage Therapeutics’ Brain Targeting Liposome System
by Editorial Staff | May 24, 2021 | Press Release | 0
NEW YORK, May 24, 2021 /PRNewswire/ — MindMed (NASDAQ: MNMD, NEO: MMED, DE: MMQ),...
Read MoreMindMed Announces the Approval of Mescaline Study
by Editorial Staff | May 20, 2021 | Press Release | 0
BASEL, Switzerland, May 20, 2021 /CNW/ — MindMed (Nasdaq: MNMD) (NEO: MMED) (DE:...
Read MoreThe Chopra Foundation and MindMed Enter Into Letter of Intent to Partner on the Future of Psychedelic Medicines & Mental Wellbeing
by Editorial Staff | May 18, 2021 | Press Release | 0
NEW YORK, May 18, 2021 /PRNewswire/ — Mind Medicine (MindMed)...
Read MoreRecent Posts
-
AMD Challenges Nvidia’s Dominance in AI Chip MarketOct 11, 2024 | Business